Deferred Tax Assets, Valuation Allowance of Encompass Health Corp from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Encompass Health Corp quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Encompass Health Corp Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $21,400,000, a 1.9% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Encompass Health Corp Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $21,400,000 +$400,000 +1.9% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q4 2024 $21,000,000 -$7,400,000 -26% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q4 2023 $28,400,000 -$7,400,000 -21% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q4 2022 $35,800,000 -$7,300,000 -17% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q4 2021 $43,100,000 -$3,100,000 -6.7% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q4 2020 $46,200,000 +$7,800,000 +20% 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q4 2019 $38,400,000 +$4,700,000 +14% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 $35,300,000 -$1,800,000 -4.9% 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $34,300,000 -$2,400,000 -6.5% 30 Jun 2019 10-Q 31 Jul 2019 2019 Q2
Q1 2019 $34,500,000 -$1,700,000 -4.7% 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 $33,700,000 -$2,100,000 -5.9% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q3 2018 $37,100,000 +$8,700,000 +31% 30 Sep 2018 10-Q 31 Oct 2018 2018 Q3
Q2 2018 $36,700,000 +$8,400,000 +30% 30 Jun 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 $36,200,000 +$7,300,000 +25% 31 Mar 2018 10-Q 02 May 2018 2018 Q1
Q4 2017 $35,800,000 +$7,900,000 +28% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q3 2017 $28,400,000 +$100,000 +0.35% 30 Sep 2017 10-Q 31 Oct 2017 2017 Q3
Q2 2017 $28,300,000 +$700,000 +2.5% 30 Jun 2017 10-Q 02 Aug 2017 2017 Q2
Q1 2017 $28,900,000 +$1,300,000 +4.7% 31 Mar 2017 10-Q 28 Apr 2017 2017 Q1
Q4 2016 $27,900,000 +$300,000 +1.1% 31 Dec 2016 10-K 28 Feb 2018 2017 FY
Q3 2016 $28,300,000 +$5,400,000 +24% 30 Sep 2016 10-Q 28 Oct 2016 2016 Q3
Q2 2016 $27,600,000 +$4,600,000 +20% 30 Jun 2016 10-Q 29 Jul 2016 2015 Q2
Q1 2016 $27,600,000 +$4,600,000 +20% 31 Mar 2016 10-Q 28 Apr 2016 2015 Q1
Q4 2015 $27,600,000 +$4,600,000 +20% 31 Dec 2015 8-K 19 Sep 2017 2016 FY
Q3 2015 $22,900,000 -$7,400,000 -24% 30 Sep 2015 10-Q 29 Oct 2015 2015 Q3
Q2 2015 $23,000,000 -$7,300,000 -24% 30 Jun 2015 10-Q 30 Jul 2015 2015 Q2
Q1 2015 $23,000,000 -$7,300,000 -24% 31 Mar 2015 10-Q 01 May 2015 2015 Q1
Q4 2014 $23,000,000 -$7,700,000 -25% 31 Dec 2014 10-K 25 Feb 2016 2015 FY
Q3 2014 $30,300,000 -$5,300,000 -15% 30 Sep 2014 10-Q 28 Oct 2014 2014 Q3
Q2 2014 $30,300,000 -$6,900,000 -19% 30 Jun 2014 10-Q 29 Jul 2014 2014 Q2
Q1 2014 $30,300,000 -$9,500,000 -24% 31 Mar 2014 10-Q 29 Apr 2014 2014 Q1
Q4 2013 $30,700,000 -$9,100,000 -23% 31 Dec 2013 10-K 02 Mar 2015 2014 FY
Q3 2013 $35,600,000 -$13,500,000 -27% 30 Sep 2013 10-Q 29 Oct 2013 2013 Q3
Q2 2013 $37,200,000 -$12,800,000 -26% 30 Jun 2013 10-Q 30 Jul 2013 2013 Q2
Q1 2013 $39,800,000 -$10,500,000 -21% 31 Mar 2013 10-Q 26 Apr 2013 2013 Q1
Q4 2012 $39,800,000 -$10,500,000 -21% 31 Dec 2012 10-K 20 Feb 2014 2013 FY
Q3 2012 $49,100,000 -$55,900,000 -53% 30 Sep 2012 10-Q 26 Oct 2012 2012 Q3
Q2 2012 $50,000,000 -$56,000,000 -53% 30 Jun 2012 10-Q 27 Jul 2012 2012 Q2
Q1 2012 $50,300,000 31 Mar 2012 10-Q 01 May 2012 2012 Q1
Q4 2011 $50,300,000 -$62,400,000 -55% 31 Dec 2011 10-K 19 Feb 2013 2012 FY
Q3 2011 $105,000,000 30 Sep 2011 10-Q 04 Nov 2011 2011 Q3
Q2 2011 $106,000,000 30 Jun 2011 10-Q 04 Aug 2011 2011 Q2
Q4 2010 $112,700,000 31 Dec 2010 8-K 06 Sep 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.